Session Details

[3-P]Poster

Wed. Mar 18, 2026 1:00 PM - 2:00 PM JST
Wed. Mar 18, 2026 4:00 AM - 5:00 AM UTC
Poster (Lecture Building)(C201)

[3-P-001]Establishment of drug evaluation system in intravenous dissemination model of Burkitt lymphoma using IVIS

*Misato Moriguchi1, Shinichiro Tsunesumi1, Zhe Sun1, Shigenori Enoki1, Kosuke Morizumi1 (1. Mediford Corporation Drug Discovery Innovation Center Research Unit Ⅰ)
Comment()

[3-P-002]Ghrelin signaling in the brain suppresses cancer metastasis by activating anti-tumor immunity

*Tomohiro Shibata1, Daiki Masukawa1, Koichi Yoshida1, Takeshi Tokudome1 (1. Yokohama City University Graduate School of Medicine)
Comment()

[3-P-003]Analysis of the effects of high LPP3 expression in alveolar epithelial cells on lung fibrosis

*Yasuhiro Takenouchi1, Rikuto Miyoshi2, Keisuke Kitakaze1, Rie Sugimoto1, Kazuhito Tsuboi1, Yuko Ito1, Yasuo Okamoto1 (1. Kawasaki Med. Sch., 2. Kawasaki Univ. Med. Welfare)
Comment()

[3-P-004]D-amino acids involved in regulation of D-amino acid oxidase, PCMT1, mitochondria in A549 cells

*Masahito Ogasawara1, Iwao Takahashi1, Hiroaki Naraba1, Keishi Ohtsu2, Hisayo Fukuda3 (1. Iwate Medical University School of Pharmacy, 2. Iwate Medical University School of Dentistry, 3. Aichi Gakuin University School of Dentistry)
Comment()

[3-P-005]Comparative analysis of airway inflammatory to combustible and heated tobacco exposure in mice

*Genki Kimura1, Taiki Nakajima1, Tomohiro Miyasaka1 (1. Nihon Univ. Sch. Pharmacy)
Comment()

[3-P-006]The expression analysis of discoidin domain receptor 1 (DDR1) in the murine asthma model showing lung fibrosis

*Yuya Sannomiya1, Momoka Makishima1, Ryotaro Endo1, Mana Nakayama1, Hayato Shimora1, Masaya Matsuda1, Takeshi Nabe1 (1. Setsunan University)
Comment()

[3-P-007]Involvement of Focal Adhesion Kinase (FAK) on protective effect of IL-4/IL-13 in senescent cell

*Takashi Nishinaka1, Hidenori Wake1, Masahiro Watanabe2, Takao Toyomura2, Mori Shuji2, Masahiro Nishibori3, Takahashi Hideo1 (1. Dept. Pharmacol., Facul. Med., Kindai Univ., 2. Dept. Pharmcol., Sch. Pharmacy, Shujitsu Univ., 3. Dept. Transl. Res. Drug Dev., Okayama Univ.)
Comment()

[3-P-008]Comparative Immunopathology of Aspergillus and Alternaria-Induced Chronic Asthma in Mice

*Masato Kawano1, Ayano Sato2, Minori Chiba2, Chiharu Ohira2, Mao Kaneki2, Hideka Hasegawa1, Kazuki Koibuchi1, Ryusei Anno1, Tomoki Fukuyama1,2 (1. Azabu University Faculty of Veterinary Medicine, 2. Lab. of Pharmacol., Grab. Sch. of Vet. Med., Azabu Univ.)
Comment()

[3-P-009]Inflammatory priming facilitates IL-4-induced M2 polarization in RAW264.7 macrophages

*Saki Shiga1, Natsumi Mizuno1, Yoshiki Yanagawa1 (1. Dept. of Pharmacology, school of Pharmacy, Health Sci. Univ. of Hokkaido)
Comment()

[3-P-010]Effect of CDK8/19 inhibition on IL-4-induced arginase-1 via p38 MAPK and possible ERK5 involvement.

*Natsumi Mizuno1, Saki Shiga1, Yoshiki Yanagawa1 (1. Dept. of Pharmacology, School of Pharmacy, Health Sci. Univ. of Hokkaido)
Comment()

[3-P-011]Probiotic Effects of Canine-Derived Lactobacillus acidophilus on Th2 Immune Modulation through the Gut–Lung Axis

*Ayano Sato2, Mao Kaneki2, Tiharu Oohira2, Minori Tiba2, Tetta Hiwatashi1, Kaho Keimatsu2, Yuzuki Hishikawa1, Tomoki Hukuyama1,2 (1. Azabu University Faculty of Veterinary Medicine, 2. Lab. of Pharmacol., Grad. Sch. of Vet. Med., Azabu Univ.)
Comment()

[3-P-012]Differential Impacts of Animal- and Plant-Derived Proteins on Carcinogenesis and Inflammatory Responses

*Yuta Kaga1, Aika Hamauzu2, Yukari Inaba2, Chiharu Ohira2, Mao Kaneki2, Nana Komai1, Tomoki Fukuyama1,2 (1. Azabu University Faculty of Veterinary Medicine, 2. Lab. of Pharmacol., Grad. Sch. of Vet. Med., Azabu Univ.)
Comment()

[3-P-013]Effect of indoor air quality control on allergic mouse models and VOC levels in veterinary hospitals

*Kengo Tomita1, Chiharu Ohira2, Yukiko Ota1, Keiichi Yano1, Mona Amano1, Mao Kaneki2, Atsushi Yamada3, Riku Usui3, Yuzo Nagai3, Masaki Nagane4, Satoshi Takagi5, Tomoki Fukuyama2 (1. Institute of Technology, Shimizu Corporation, 2. Pharmacology lab, Vet Med, Azabu Univ. , 3. Fuji Industrial Co., Ltd, 4. Biochemistry lab, Vet Med, Azabu Univ. , 5. Small Animal Surgery lab, Vet Med, Azabu Univ.)
Comment()

[3-P-014]Plasminogen Receptor Plg-RKT–Mediated Regulation of Macrophage Function in the Promotion of Atherosclerosis in Mice

*Yasuki Matano1, Takayuki Iwaki1, Yohei Okubo1, Kazuo Umemura1 (1. Hamamatsu University School of Medicine)
Comment()

[3-P-015]Reactive oxygen species-induced pro-inflammatory cytokine production via TRPM2-mediated Ca2+ influx in canine peripheral blood mononuclear cells

*Takuya Yamaguchi1, Naoto Ueda1, Jun Yamazaki1 (1. Nihon University College of Bioresource Sciences)
Comment()

[3-P-016]Role of GPR3 in regulating apoptosis in T cells under PMA/ionomycin stimulation

*Hiroko Shiraki1, Shigeru Tanaka1, Kana Harada1, Norio Sakai1 (1. Hiroshima University Graduate School of Biomedical and Health Sciences)
Comment()

[3-P-017]Mechanism of the PPARα-independent inhibition pathway of cysteinyl leukotrienes in mast cells (Part 3)

*Masamichi Yamashita Yamashita1 (1. Nihon University)
Comment()

[3-P-018]Analysis of hypoxia-inducible factor induced tumor inhibition factor in tumor infiltrating macrophage

*Shinji Matsunaga1, Takujiro Homma1, Ryo Hirakawa1, Shuhei Tomita1 (1. Osaka Metropolitan University Graduate School of Medicine)
Comment()

[3-P-019]Network-guided combination therapy design targeting GPX4 and FAK for efficient ferroptosis induction

*Rina Kunishige1,2, Yoshiyuki Yoshiyuki2,3, Naomi Okamoto2,5, Lei Li2, Akito Ono4, Masayuki Murata1,2, Fumi Kano1 (1. Institute of Science Tokyo, 2. Cellshoot Therapeutics, Inc., 3. University of Tokyo, 4. Axcelead Drug Discovery Partners, Inc., 5. Kanagawa Institute of Industrial Science and Technology)
Comment()

[3-P-020]Study on the mechanisms of purine derivatives-induced promotion of cysteine uptake

*Nobuko Matsumura1, Wattanaporn Bhadhprasit Sumida1, Chisato Kinoshita1, Koji Aoyama1 (1. Teikyo University School of Medicine)
Comment()